These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3234542)

  • 1. [Interaction of the calcium salt of heparin with specific antagonists and ethacizine].
    Ushkalova EA; Petrov AD; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(6):53-6. PubMed ID: 3234542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of etatsizin on blood coagulability and the anticoagulant effect of heparin].
    Petrov AD
    Farmakol Toksikol; 1985; 48(4):112-4. PubMed ID: 4043358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the interrelations of ethmozine, cordarone and phenycaberan with heparin].
    Tolstopiatov BI
    Farmakol Toksikol; 1981; 44(5):586-9. PubMed ID: 7030776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction studies with metolazone, heparin and protamine sulfate.
    Yelnosky J; Borrelli A; Kaiser F; Belair E
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):5-11. PubMed ID: 4746632
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate.
    Adkins JR; Hardy JD
    Arch Surg; 1967 Feb; 94(2):175-7. PubMed ID: 6016262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of heparin and LMW heparin on hemostasis.
    Hirsh J; Buchanan MR
    Thromb Res Suppl; 1991; 14():11-7. PubMed ID: 1658966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragments.
    Racanelli A; Fareed J; Walenga JM; Coyne E
    Semin Thromb Hemost; 1985 Apr; 11(2):176-89. PubMed ID: 4035365
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of heparin and protamine in presence of overdosage: in vitro study.
    Hanke AA; Severloh I; Flöricke F; Weber CF; Lang T
    Asian Cardiovasc Thorac Ann; 2021 Jan; 29(1):5-9. PubMed ID: 32854516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
    Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
    J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
    Soulier JP; Gozin D; Lerable J
    Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.